These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 29380942

  • 1. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
    Tanis JB, Mason SL, Maddox TW, Blackwood L, Killick DR, Amores-Fuster I, Harper A, Finotello R.
    Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
    [Abstract] [Full Text] [Related]

  • 2. Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
    Morgan E, O'Connell K, Thomson M, Griffin A.
    Vet Comp Oncol; 2018 Dec; 16(4):622-629. PubMed ID: 30117253
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience.
    Smallwood K, Tanis JB, Grant IA, Blackwood L, Killick DR, Amores-Fuster I, Elliott J, Mas A, Harper A, Marrington M, Finotello R.
    Vet Comp Oncol; 2019 Jun; 17(2):165-173. PubMed ID: 30666777
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Retrospective Study of Multi-agent Chemotherapy including either Cyclophosphamide or Lomustine as Initial Therapy for Canine High-grade T-cell Lymphoma (2011-2017).
    Elliott J, Baines S.
    Aust Vet J; 2019 Sep; 97(9):308-315. PubMed ID: 31328256
    [Abstract] [Full Text] [Related]

  • 7. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
    Blaxill J, Buzzacott P, Finlay J.
    Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024
    [Abstract] [Full Text] [Related]

  • 8. Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.
    Rassnick KM, Bailey DB, Malone EK, Intile JL, Kiselow MA, Flory AB, Barlow LL, Balkman CE, Barnard SM, Waite AH.
    Vet Comp Oncol; 2010 Dec; 8(4):243-53. PubMed ID: 21062406
    [Abstract] [Full Text] [Related]

  • 9. Procarbazine, prednisolone and cyclophosphamide oral combination chemotherapy protocol for canine lymphoma.
    O'Connell K, Thomson M, Morgan E, Henning J.
    Vet Comp Oncol; 2022 Sep; 20(3):613-622. PubMed ID: 35338560
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
    Saba CF, Thamm DH, Vail DM.
    J Vet Intern Med; 2007 Sep; 21(1):127-32. PubMed ID: 17338160
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and toxicity of BOPP and LOPP chemotherapy for the treatment of relapsed canine lymphoma.
    LeBlanc AK, Mauldin GE, Milner RJ, LaDue TA, Mauldin GN, Bartges JW.
    Vet Comp Oncol; 2006 Mar; 4(1):21-32. PubMed ID: 19754826
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
    Zimmerman K, Walsh KA, Ferrari JT, Keuler NS, Atherton MJ, Lenz JA.
    Vet Comp Oncol; 2023 Sep; 21(3):503-508. PubMed ID: 37222086
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma.
    Saba CF, Hafeman SD, Vail DM, Thamm DH.
    J Vet Intern Med; 2009 Sep; 23(5):1058-63. PubMed ID: 19678892
    [Abstract] [Full Text] [Related]

  • 14. Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
    Koza I, Bohunický L, Mociková K, Gyárfás J, Svancárová L, Mardiak J, Spánik S, Fuchsberger P, Thalmeinerová Z, Sufliarsky J.
    Neoplasma; 1991 Sep; 38(6):583-93. PubMed ID: 1722564
    [Abstract] [Full Text] [Related]

  • 15. Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
    Curran K, Thamm DH.
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():147-55. PubMed ID: 26279153
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.
    Rassnick KM, Moore AS, Collister KE, Northrup NC, Kristal O, Chretin JD, Bailey DB.
    J Vet Intern Med; 2009 Aug; 23(2):317-22. PubMed ID: 19192147
    [Abstract] [Full Text] [Related]

  • 17. Use of Lomustine and Prednisolone as First-Line Treatment in Canine Multicentric Lymphoma.
    Catalucci C, Bianchi ML, Treggiari E, Pieri M, Ruess K, Valenti P.
    Vet Comp Oncol; 2024 Sep; 22(3):422-428. PubMed ID: 38890811
    [Abstract] [Full Text] [Related]

  • 18. Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link?
    Wang SL, Lee JJ, Liao AT.
    Vet J; 2016 Jul; 213():87-9. PubMed ID: 27240922
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma.
    Parker AS, Burton JH, Curran KM, Wolf-Ringwall A, Thamm DH.
    J Vet Intern Med; 2024 Jul; 38(4):2282-2292. PubMed ID: 38961691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.